Literature DB >> 12498971

Progressive age-related impairment of cognitive behavior in APP23 transgenic mice.

P H Kelly1, L Bondolfi, D Hunziker, H-P Schlecht, K Carver, E Maguire, D Abramowski, K-H Wiederhold, C Sturchler-Pierrat, M Jucker, R Bergmann, M Staufenbiel, B Sommer.   

Abstract

Transgenic APP23 mice expressing human APP(751) with the K670N/M671L mutation, were compared at ages 3, 18 or 25 months to non-transgenic littermates in passive avoidance and in a small and large Morris maze. The task in the smaller pool habituated their flight response to the platform. Impairments in passive avoidance and small pool performance in APP23 mice were clearly age-related. In the larger Morris maze APP23 mice at all ages were impaired in latency and distance swum before finding the platform. Identical performance of 18-month APP23 and controls in a visible platform condition indicates that the Morris maze performance deficit was not due to sensory, motor or motivational alterations. At age 3 months both groups initially unexpectedly avoided the visible platform, suggesting that in young mice neophobia may contribute significantly to performance in cognitive tests. In conclusion, APP23 mice exhibit both early behavioral impairment in the large Morris maze as well as impairments in passive avoidance and small pool performance that are marked only in old age.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12498971     DOI: 10.1016/s0197-4580(02)00098-2

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  42 in total

Review 1.  Genetic animal models of cerebral vasculopathies.

Authors:  Jeong Hyun Lee; Brian J Bacskai; Cenk Ayata
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

2.  Spatial navigation in complex and radial mazes in APP23 animals and neurotrophin signaling as a biological marker of early impairment.

Authors:  Rainer Hellweg; Peter Lohmann; Roman Huber; Alexander Kühl; Matthias W Riepe
Journal:  Learn Mem       Date:  2006-01-17       Impact factor: 2.460

3.  Activity-dependent neuroprotective protein (ADNP) expression in the amyloid precursor protein/presenilin 1 mouse model of Alzheimer's disease.

Authors:  Rafael Fernandez-Montesinos; Manuel Torres; David Baglietto-Vargas; Antonia Gutierrez; Illana Gozes; Javier Vitorica; David Pozo
Journal:  J Mol Neurosci       Date:  2009-10-21       Impact factor: 3.444

Review 4.  Olfactory dysfunction: its early temporal relationship and neural correlates in the pathogenesis of Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  J Neural Transm (Vienna)       Date:  2015-05-06       Impact factor: 3.575

5.  Dinitrobenzene sulphonic acid-induced colitis impairs spatial recognition memory in mice: roles of N-methyl D-aspartate receptors and nitric oxide.

Authors:  Mohammad Hadi Gharedaghi; Reza Rahimian; Ahmad Reza Dehpour; Yashar Yousefzadeh-Fard; Ahmad Mohammadi-Farani
Journal:  Psychopharmacology (Berl)       Date:  2015-05-14       Impact factor: 4.530

6.  Impaired rapid eye movement sleep in the Tg2576 APP murine model of Alzheimer's disease with injury to pedunculopontine cholinergic neurons.

Authors:  Bin Zhang; Sigrid C Veasey; Marcelo A Wood; Lewis Z Leng; Christine Kaminski; Susan Leight; Ted Abel; Virginia M-Y Lee; John Q Trojanowski
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

7.  Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model.

Authors:  Debby Van Dam; Dorothee Abramowski; Matthias Staufenbiel; Peter Paul De Deyn
Journal:  Psychopharmacology (Berl)       Date:  2005-01-15       Impact factor: 4.530

Review 8.  Improved behavioral response as a valid biomarker for drug screening program in transgenic rodent models of tauopathies.

Authors:  Miroslava Korenova; Zuzana Stozicka
Journal:  Cell Mol Neurobiol       Date:  2009-03-13       Impact factor: 5.046

9.  Metabolites of cerebellar neurons and hippocampal neurons play opposite roles in pathogenesis of Alzheimer's disease.

Authors:  Jing Du; Bing Sun; Kui Chen; Lang Zhang; Shubo Liu; Qingquan Gu; Li Fan; Nanming Zhao; Zhao Wang
Journal:  PLoS One       Date:  2009-05-13       Impact factor: 3.240

10.  COL25A1 triggers and promotes Alzheimer's disease-like pathology in vivo.

Authors:  Ying Tong; Ying Xu; Kimberly Scearce-Levie; Louis J Ptácek; Ying-Hui Fu
Journal:  Neurogenetics       Date:  2009-06-23       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.